John Wallace
Chairman bij Antibe Holdings, Inc.
Vermogen: 658 511 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Takashi Nagao | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | - |
Daniel Legault | M | 66 |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The private company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | 19 jaar |
Martin Kolb | M | - |
McMaster University
| - |
Juliet Daniel | F | - |
McMaster University
| - |
Barry Nicol | M | - |
McMaster University
| - |
David Huctwith | M | - |
McMaster University
| - |
Christina Cameron | F | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | - |
Arjun Kumar | M | - |
McMaster University
| - |
John Manley | M | 74 |
McMaster University
| - |
Michael Verbora | M | - |
McMaster University
| 6 jaar |
Khaled Hassanein | M | - |
McMaster University
| - |
Sonny Kohli | M | - |
McMaster University
| 14 jaar |
James Macpherson | M | - |
McMaster University
| - |
John Valliant | M | 54 |
McMaster University
| 25 jaar |
Natalia K. Nikolova | M | - |
McMaster University
| 25 jaar |
Matsuo Kikuchi | M | 64 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 8 jaar |
Michael Ferencich | M | - |
McMaster University
| - |
Christina Bryce | F | - |
McMaster University
| - |
Stephanie Baschiera | F | - |
McMaster University
| - |
Marc Letendre | M | - |
McMaster University
| - |
Jeanne Tan | F | - |
McMaster University
| - |
Chris Sinding | M | - |
McMaster University
| - |
Arlene Dosen | F | - |
McMaster University
| - |
Jerry Hurley | M | - |
McMaster University
| - |
Pamela Swett | F | - |
McMaster University
| - |
Karen Mossaman | F | - |
McMaster University
| - |
Fiona McNeill | F | - |
McMaster University
| - |
Joseph Gabriele | M | - |
McMaster University
| - |
Judith Shedden | F | - |
McMaster University
| - |
Sara Bannerman | F | - |
McMaster University
| - |
Spencer Pope | M | - |
McMaster University
| - |
Judy West-Mays | F | - |
McMaster University
| - |
Sandeep Raha | M | - |
McMaster University
| - |
Dean Mountain | M | - |
McMaster University
| - |
To fart Luongo | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 jaar |
Jeffrey Weitz | M | - |
McMaster University
| - |
Marion B. Lyver | M | - |
McMaster University
| - |
Peter Horsewood | M | - |
McMaster University
| - |
Fraser Reeve Berrill | M | 75 |
McMaster University
| - |
H. Barber | M | - |
McMaster University
| - |
Jim A. Wright | M | - |
McMaster University
| 14 jaar |
Rocco Taglioni | M | - |
McMaster University
| - |
Kevin P. D. Smith | M | 61 |
McMaster University
| - |
Richard Rossman | M | - |
McMaster University
| - |
Paul D. Campbell | M | 76 |
McMaster University
| - |
James B. Mahony | M | - |
McMaster University
| - |
Emõke J. E. Szathmáry | M | 81 |
McMaster University
| - |
James Paul | M | - |
McMaster University
| - |
Robert G. Cooper | M | - |
McMaster University
| - |
John Bienenstock | M | 87 |
McMaster University
| - |
Ronald Campbell Loucks | M | - |
McMaster University
| - |
Mary Maher | F | 63 |
McMaster University
| - |
Grant B. Walsh | M | 75 |
McMaster University
| - |
Lynton R. Wilson | M | 84 |
McMaster University
| - |
Yoshihisa Sasou | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 jaar |
Michael T. Newhouse | M | - |
McMaster University
| - |
Marc-André D'Aoust | M | - |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 25 jaar |
David Vaughan | M | 74 |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The private company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | 17 jaar |
John C. Luxat | M | - |
McMaster University
| - |
Woo-Young Kim | M | - |
McMaster University
| 13 jaar |
Seiichi Murakami | M | 67 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | 11 jaar |
Connie A. Stefankiewicz | F | - |
McMaster University
| - |
Mark Larché | M | - |
McMaster University
| - |
Gary Kain | M | - |
McMaster University
| - |
Marc Kealey | M | - |
McMaster University
| - |
Paul Dixon Allison | M | - |
McMaster University
| - |
Yaser M. Haddara | M | - |
McMaster University
| - |
Emechete Onuoha | M | - |
McMaster University
| - |
Roger Couldrey | M | - |
McMaster University
| - |
S. R. Rafael Jose Faucher | M | - |
McMaster University
| - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Canada | 70 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- John Wallace
- Persoonlijk netwerk